Lurasidone hydrochloride ( —— )

产品货号. M14263 CAS No. 367514-88-3

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

拼团产品询价大包装询价加入购物车

产品名称

Lurasidone hydrochloride
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma.
产品描述

Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma. It was approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia on October 29, 2010 and is currently pending approval for the treatment of bipolar disorder in the United States.
同义词

——
通路

Endocrinology/Hormones
靶点

5-HT Receptor
受体

5-HT1A; 5-HT2A; 5-HT7; D2; Norepinephrine α2C
研究领域

Neurological Disease
适应症

——

CAS Number

367514-88-3
分子量

529.14
分子式

C28H36N4O2S·HCl
纯度

>98%(HPLC)
溶解度

DMSO: 1 mg/mL (1.88 mM)
SMILES

C1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O.Cl
化学全称

——

1.Murai T, et al. Behav Brain Res. 2014 Mar 15;261:26-30.

计算器

产品手册

关联产品

SB 204741

5-HT2B receptor antagonist.
Mebhydrolin napadisy...

Mebhydrolin (napadisylate) is an antihistamine, used for symptomatic relief of allergic symptoms caused by histamine release.
Dehydroaripiprazole

Dehydroaripiprazole is the active metabolite of aripiprazole. Aripiprazole is an antipsychotic drug, which is metabolized by CYP3A4 and CYP2D6 and mainly forms dehydroaripiprazole.